As of April 2024 Vaxart has a market cap of $0.13 Billion. This makes Vaxart the world's 7204th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.13 B | 50.85% |
2023 | $87.08 M | -30.95% |
2022 | $0.12 B | -83.97% |
2021 | $0.78 B | 25.88% |
2020 | $0.62 B | 3595.7% |
2019 | $16.91 M | 25.98% |
2018 | $13.42 M | -38.66% |
2017 | $21.88 M | -53.95% |
2016 | $47.52 M | -36.59% |
2015 | $74.95 M | -4.67% |
2014 | $78.62 M | -33.84% |
2013 | $0.11 B | 5.05% |
2012 | $0.11 B | 40.31% |
2011 | $80.62 M | -67.24% |
2010 | $0.24 B | 0.76% |
2009 | $0.24 B | 40.39% |
2008 | $0.17 B | -14.4% |
2007 | $0.20 B | -50.59% |
2006 | $0.41 B | 104.51% |
2005 | $0.20 B | -76.58% |
2004 | $0.85 B | 18.71% |
2003 | $0.72 B | 202.62% |
2002 | $0.23 B | -39.47% |
2001 | $0.39 B |
On Apr 19th, 2024 the market cap of Vaxart was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | -86.11% | Bahamas |
NRC Health
NRC | $0.81 B | 518.37% | ๐บ๐ธ USA |